Listar por autor "Malo Manso, A"
Mostrando ítems 1-2 de 2
-
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists.
Guerrero-Orriach, José Luis
; Navarro Arce, I; Hernandez Rodriguez, P; Raigón Ponferrada, Aída; Malo Manso, A; Ramirez Aliaga, M; Ramirez Fernandez, A; Escalona Belmonte, JJ; Bellido-Estévez, Inmaculada; Gómez-Luque, José Aurelio; Barrera Serrano, R; Toledo Medina, CS; Rubio-Navarro, Manuel; Cruz Mañas, J[et al.] (Springer Nature, 2019-11-17)
Background Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative ... -
Renal and neurologic benefit of levosimendan vs dobutamine in patients with low cardiac output syndrome after cardiac surgery: Clinical trial FIM-BGC-2014-01
Guerrero-Orriach, José Luis; Malo Manso, A; Ramirez Aliaga, M; Florez Vela, AI; Galan Ortega, M; Moreno CorteS, I; González Almendros, I; Ramirez Fernandez, A; Ariza Villanueva, D; Escalona Belmonte, JJ; Quesada MuñoZ, G; Sepulveda Haro, E; Romero Molina, S; Bellido-Estévez, Inmaculada; Gómez-Luque, José Aurelio; Rubio-Navarro, Manuel; Alcaide Torres, J; Santiago Fernández, C; Garrido Sanchez, L; Cruz Mañas, J[et al.] (Frontiers Media, 2020-08-26)
Background: Low-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available ...